A Long-term Extension Study of PCI-32765 (Ibrutinib)
for Chronic Lymphocytic Leukemia
Drug: Ibrutinib
Sites in Columbus +3 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT01804686·Phase 3·Recruiting·Listed Mar 2013